Back to Search
Start Over
Multilayered Computational Framework for Designing Peptide Inhibitors of HVEM-LIGHT Interaction.
- Source :
-
The journal of physical chemistry. B [J Phys Chem B] 2024 Jul 18; Vol. 128 (28), pp. 6770-6785. Date of Electronic Publication: 2024 Jul 03. - Publication Year :
- 2024
-
Abstract
- The herpesvirus entry mediator (HVEM) and its ligand LIGHT play crucial roles in immune system regulation, including T-cell proliferation, B-cell differentiation, and immunoglobulin secretion. However, excessive T-cell activation can lead to chronic inflammation and autoimmune diseases. Thus, inhibiting the HVEM-LIGHT interaction emerges as a promising therapeutic strategy for these conditions and in preventing adverse reactions in organ transplantation. This study focused on designing peptide inhibitors, targeting the HVEM-LIGHT interaction, using molecular dynamics (MD) simulations of 65 peptides derived from HVEM. These peptides varied in length and disulfide-bond configurations, crucial for their interaction with the LIGHT trimer. By simulating 31 HVEM domain variants, including the full-length protein, we assessed conformational changes upon LIGHT binding to understand the influence of HVEM segments and disulfide bonds on the binding mechanism. Employing multitrajectory microsecond-scale, all-atom MD simulations and molecular mechanics with generalized Born and surface area (MM-GBSA) binding energy estimation, we identified promising CRD2 domain variants with high LIGHT affinity. Notably, point mutations in these variants led to a peptide with a single disulfide bond (C58-C73) and a K54E substitution, exhibiting the highest binding affinity. The importance of the CRD2 domain and Cys58-Cys73 disulfide bond for interrupting HVEM-LIGHT interaction was further supported by analyzing truncated CRD2 variants, demonstrating similar binding strengths and mechanisms. Further investigations into the binding mechanism utilized steered MD simulations at various pulling speeds and umbrella sampling to estimate the energy profile of HVEM-based inhibitors with LIGHT. These comprehensive analyses revealed key interactions and different binding mechanisms, highlighting the increased binding affinity of selected peptide variants. Experimental circular dichroism techniques confirmed the structural properties of these variants. This study not only advances our understanding of the molecular basis of HVEM-LIGHT interactions but also provides a foundation for developing novel therapeutic strategies for immune-related disorders. Furthermore, it sets a gold standard for peptide inhibitor design in drug development due to its systematic approach.
- Subjects :
- Humans
Tumor Necrosis Factor Ligand Superfamily Member 14 chemistry
Tumor Necrosis Factor Ligand Superfamily Member 14 metabolism
Drug Design
Amino Acid Sequence
Thermodynamics
Molecular Dynamics Simulation
Peptides chemistry
Peptides metabolism
Peptides pharmacology
Receptors, Tumor Necrosis Factor, Member 14 chemistry
Receptors, Tumor Necrosis Factor, Member 14 metabolism
Protein Binding
Subjects
Details
- Language :
- English
- ISSN :
- 1520-5207
- Volume :
- 128
- Issue :
- 28
- Database :
- MEDLINE
- Journal :
- The journal of physical chemistry. B
- Publication Type :
- Academic Journal
- Accession number :
- 38958133
- Full Text :
- https://doi.org/10.1021/acs.jpcb.4c02255